Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantation

Nephrology Dialysis Transplantation

Volumn 23, Issue 1, 2008, Pages 359-363

  Philibert, David ^a   Desmeules, Simon ^a   Filion, Alain ^b   Poirier, Mireille ^b   Agharazii, Mohsen ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Electrolyte abnormalities; Haematopoietic stem cell transplant; Hypocalcaemia; Hypokalaemia; Hypomagnesaemia; Hypophosphataemia

Indexed keywords

ALBUMIN; AMPHOTERICIN B; CALCIUM; FUROSEMIDE; MAGNESIUM; PHOSPHORUS; POTASSIUM;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; FEMALE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; INCIDENCE; LYMPHOMA; MALE; MULTIPLE MYELOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; HOSPITALIZATION; METABOLIC DISORDER; MIDDLE AGED; TIME;

ADULT; AGED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WATER-ELECTROLYTE IMBALANCE;

EID: 44449127153     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm571     Document Type: Article

References (34)

1. Loberiza F. Report on state of the art in blood and marrow transplantation. Int Bone Marrow Transpl Registry News 2003; 10: 1-12
2. Sniecinski IJ, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988; 45: 530-534
3. Parikh CR, McSweeney PA, Korular D et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 2002; 62: 566-573
4. Humphreys BD, Soiffer RJ, Magee CC. Renal failure associated with cancer and its treatment: an update. J Am Soc Nephrol 2005; 16: 151-161
5. Antignac C, Gubler MC, Leverger G, Broyer M, Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 1989; 35: 1336-1344
6. Takatsuka H, Wakae T, Mori A et al. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 29: 907-911
7. Loomis LJ, Aronson AJ, Rudinsky R, Spargo BH. Hemolytic uremic syndrome following bone marrow transplantation: a case report and review of the literature. Am J Kidney Dis 1989; 14: 324-328
8. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int 1994; 46: 1443-1458
9. Reddy P, Johnson K, Uberti JP et al. Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 351-357
10. Colombo AA, Rusconi C, Esposito C et al. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease. Transplantation 2006; 81: 1087-1092
11. Sato Y, Hara S, Fujimoto S et al. Minimal change nephrotic syndrome after allogenic hematopoietic stem cell transplantation. Intern Med 2004; 43: 512-515
12. James GW,III, Abbott LD,Jr. Metabolic studies in pernicious anemia. I. Nitrogen and phosphorus metabolism during B12-induced remission. Metabolism 1952; 52: 259-270
13. Lawson DH, Murray RM, Parker JL. Early mortality in the megaloblastic anaemias. Q J Med 1972; 41: 1-14
14. Schiffman FJ, Schiffman RL, Rosa RM. Cellular proliferation and hypokalemia. Ann Intern Med 1977; 87: 635-636
15. Wollner A, Shalit M, Brezis M. Tumor genesis syndrome. Hypophosphatemia accompanying Burkitt's lymphoma cell leukemia. Miner Electrolyte Metab 1986; 12: 173-175
16. Suki WN, Martinez-Maldonado M, Rouse D, Terry A. Effect of expansion of extracellular fluid volume on renal phosphate handling. J Clin Invest 1969; 48: 1888-1894
17. Massry SG, Coburn JW, Kleeman CR. The influence of extracellular volume expansion on renal phosphate reabsorption in the dog. J Clin Invest 1969; 48: 1237-1245
18. White MG, van Gelder J, Eastes G. The effect of loop diuretics on the excretion of Na+, Ca2+, Mg2+, and Cl-. J Clin Pharmacol 1981; 21: 610-614
19. Di tefano A, Roinel N, de Rouffignac C, Wittner M. Transepithelial Ca2+ and Mg2+ transport in the cortical thick ascending limb of Henle's loop of the mouse is a voltage-dependent process. Ren Physiol Biochem 1993; 16: 157-166
20. Sebastian A, Hernandez RE, Portale AA et al. Dietary potassium influences kidney maintenance of serum phosphorus concentration. Kidney Int 1990; 37: 1341-1349
21. Lemann J, Jr, Pleuss JA, Gray RW, Hoffmann RG. Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults. Kidney Int 1991; 39: 973-983
22. Agus ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10: 161616-22
23. Shils ME. Experimental human magnesium depletion. Medicine (Baltimore) 1969; 48: 61-85
24. Whang R, Welt LG. Observations in experimental magnesium depletion. J Clin Invest 1963; 42: 305-313
25. Ginn HE, Shanbour LL. Phosphaturia in magnesium-deficient rats. Am J Physiol 1967; 212: 1347-1350
26. Chase LR, Slatopolsky E. Secretion and metabolic efficacy of parthyroid hormone in patients with severe hypomagnesemia. J Clin Endocrinol Metab 1974; 38: 363-371
27. Rude RK, Oldham SB, Singer FR. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 1976; 5: 209-224
28. Fatemi S, Ryzen E, Flores J, Endres DB, Rude RK. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J Clin Endocrinol Metab 1991; 73: 1067-1072
29. Berenson JR, Lichtenstein A, Porter L et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med 1996; 334: 488-493
30. Berenson JR, Lichtenstein A, Porter L et al. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group. J Clin Oncol 1998; 16: 593-602
31. Nussbaum SR, Younger J, Vandepol CJ et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages. Am J Med 1993; 95: 297-304
32. Elisaf M, Kalaitzidis R, Siamopoulos KC. Multiple electrolyte abnormalities after pamidronate administration. Nephron 1998; 79: 337-339
33. Schulte C, Beelen DW, Schaefer UW, Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos Int 2000; 11: 344-353
34. Kreutz M, Eissner G, Hahn J et al. Variations in 1 alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 33: 871-873